The Providers Clinical Support System (PCSS) is offering several free CME opportunities, available on demand.
This webinar, conducted in January, sheds light on the relationship between mental health disorders and opioid use disorders, as well as how this relationship impacts the treatment of both. (1 AAPA Category 1 CME credit)
This webinar from February discusses several newly approved, long-acting buprenorphine formulations and how to better use these products for the treatment of patients with opioid use disorder. (1 AAPA Category 1 CME credit)
This Performance Improvement activity assists participants in identifying and addressing current practice gaps related to the treatment of patients with opioid use disorder. (Up to 20 AAPA Category 1 CME credits)
The training is required for PAs to receive their DEA X-waiver to prescribe buprenorphine, one of three medications approved by the FDA for the treatment of opioid use disorder. (Up to 24 AAPA Category 1 CME credits)